Practical Management of Everolimus-Related Toxicities in Patients with Advanced Solid Tumors
Viktor Grünwald(Deutsche Schmerzgesellschaft), Matthias M. Weber(Johannes Gutenberg University Mainz), Diana Lüftner(Beiersdorf (Germany)), Wolfgang Janni(Grace (United States)), Dieter Hörsch(Philipps University of Marburg), Steffen Weikert(St. Hedwig-Krankenhaus), Marianne Pavel(Universitätsklinikum Erlangen), Matthias Geberth(Praxis für Hämatologie und Onkologie)
Cited by 34
Related Papers
The Epidemiology of Renal Cell Carcinoma
|European Urology|2011|1k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
|Annals of Oncology|2015|698
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial
|The Lancet Oncology|2017|431
Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group
|Journal of Clinical Oncology|2006|409